Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics Revenue

Relay Therapeutics had revenue of $3.00M in the quarter ending March 31, 2026, a decrease of -60.93%. This brings the company's revenue in the last twelve months to $10.68M, up 39.04% year-over-year. In the year 2025, Relay Therapeutics had annual revenue of $15.36M with 53.44% growth.

• Revenue (ttm): $10.68M
• Revenue Growth: +39.04%
• P/S Ratio: 302.33
• Revenue / Employee: $55,316
• Employees: 193
• Market Cap: 3.23B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	15.36M	5.35M	53.44%
Dec 31, 2024	10.01M	-15.54M	-60.83%
Dec 31, 2023	25.55M	24.17M	1,749.82%
Dec 31, 2022	1.38M	-1.65M	-54.41%
Dec 31, 2021	3.03M	-79.63M	-96.34%
Dec 31, 2020	82.65M	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-

Data Source: Fiscal.ai Last updated: May 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error